These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6571430

  • 1. Alport's syndrome and retinal telangiectasia.
    Kondra L, Cangemi FE, Pitta CG.
    Ann Ophthalmol; 1983 Jun; 15(6):550-1. PubMed ID: 6571430
    [Abstract] [Full Text] [Related]

  • 2. [Leber miliary aneurysms--a case report].
    Gawecki M.
    Klin Oczna; 2009 Jun; 111(4-6):131-3. PubMed ID: 19673442
    [Abstract] [Full Text] [Related]

  • 3. Ocular manifestations of Alport's syndrome: a case report.
    Acke I, Priem H.
    Bull Soc Belge Ophtalmol; 1992 Jun; 243():123-8. PubMed ID: 1302141
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alport's syndrome and flecked retinopathy.
    Gelisken O, Ozçetin H, Erturk H.
    Bull Soc Belge Ophtalmol; 1986 Jun; 220():75-9. PubMed ID: 3452470
    [No Abstract] [Full Text] [Related]

  • 6. Alport's syndrome: a case report.
    Jayaprasad B, Sathish KR, Chandrasekhar N, Upadhyaya NS, Mehta S.
    Indian J Ophthalmol; 1994 Dec; 42(4):211-2. PubMed ID: 10577000
    [No Abstract] [Full Text] [Related]

  • 7. [Retinal flecks in Alport's syndrome].
    Mili-Boussen I, Ghattas M, Ben Romdhane B, Ouertani A.
    Arch Pediatr; 2000 Dec; 7(12):1304-6. PubMed ID: 11147065
    [Abstract] [Full Text] [Related]

  • 8. Retinal abnormalities in Alport's syndrome.
    Gelisken O, Hendrikse F, Schröder CH, Berden JH.
    Acta Ophthalmol (Copenh); 1988 Dec; 66(6):713-7. PubMed ID: 3232515
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Retinal anomalies in Alport's syndrome].
    Lebuisson D, Aron JJ, Leroy L, Hascoet M.
    Bull Soc Ophtalmol Fr; 1979 Dec; 79(6-7):503-9. PubMed ID: 546541
    [No Abstract] [Full Text] [Related]

  • 11. [Ocular changes in Alport's syndrome].
    Hejcmanová D, Peregrin J, Svĕrák J, Hartmann M.
    Cesk Oftalmol; 1992 Jan; 48(1):48-53. PubMed ID: 1739998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Macular hole and Alport's syndrome].
    Rodríguez-Gil R, Gil-Hernández MA, Afonso-Rodríguez A.
    Arch Soc Esp Oftalmol; 2012 Jul; 87(7):220-4. PubMed ID: 22732121
    [Abstract] [Full Text] [Related]

  • 17. Retinal telangiectasia in association with macular hole formation.
    Jaycock PD, Thomas D, Zakir R, Laidlaw DA.
    Eye (Lond); 2004 Mar; 18(3):342-3. PubMed ID: 14716321
    [No Abstract] [Full Text] [Related]

  • 18. Parafoveal telangiectasia (PFT) has been associated with changes in macular architecture and macular holes (lamellar and full thickness).
    Rishi P, Kothari AR.
    Retina; 2008 Jan; 28(1):184-5; author reply 185-6. PubMed ID: 18185162
    [No Abstract] [Full Text] [Related]

  • 19. No association between Alport's syndrome and antithyroid antibodies.
    Lambert M, Pirson Y, De Nayer P, van Ypersele de Strihou C.
    Nephrol Dial Transplant; 1992 Jan; 7(11):1082-4. PubMed ID: 1336133
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.